207 related articles for article (PubMed ID: 24708383)
1. Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease.
Siddiqi L; Hoogduin H; Visser F; Leiner T; Mali WP; Blankestijn PJ
J Clin Hypertens (Greenwich); 2014 Mar; 16(3):214-8. PubMed ID: 24708383
[TBL] [Abstract][Full Text] [Related]
2. Imaging: BOLD assessment--effects of RAAS inhibition in CKD.
Lerman LO
Nat Rev Nephrol; 2014 May; 10(5):247-8. PubMed ID: 24662436
[No Abstract] [Full Text] [Related]
3. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
4. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
[TBL] [Abstract][Full Text] [Related]
5. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
6. Dual RAAS Blockade with Aliskiren in Patients with Severely Impaired Chronic Kidney Disease.
Rasche FM; Joel C; Ebert T; Frese T; Barinka F; Busch V; Rasche WG; Lindner TH; Schneider J; Schiekofer S
Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):39-52. PubMed ID: 28449154
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients.
Vakilzadeh N; Muller ME; Forni V; Milani B; Hoffman L; Piskunowicz M; Maillard M; Zweiacker C; Pruijm M; Burnier M
Kidney Blood Press Res; 2015; 40(5):542-54. PubMed ID: 26501147
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of aliskiren in Japanese chronic kidney disease patients with hypertension.
Sakai Y; Otsuka T; Ohno D; Murasawa T; Sato N; Mizuno K
Ren Fail; 2012; 34(4):442-7. PubMed ID: 22260457
[TBL] [Abstract][Full Text] [Related]
9. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.
Barkoudah E; van Thiel BS; Fisher ND; Gregg RA; Danser AH; Moukarbel GV; Hollenberg NK
J Hypertens; 2016 May; 34(5):935-41. PubMed ID: 26882043
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
[TBL] [Abstract][Full Text] [Related]
11. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
12. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
[TBL] [Abstract][Full Text] [Related]
13. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
14. Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans.
Pruijm M; Hofmann L; Piskunowicz M; Muller ME; Zweiacker C; Bassi I; Vogt B; Stuber M; Burnier M
PLoS One; 2014; 9(4):e95895. PubMed ID: 24760031
[TBL] [Abstract][Full Text] [Related]
15. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
Forhead AJ; Whybrew K; Hughes P; Broughton Pipkin F; Sutherland M; Fowden AL
Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the antihypertensive and anti-inflammatory effects of aliskiren and ramipril add-on therapy in peritoneal dialysis patients--a pilot open label study.
Makówka A; Olejniczak-Fortak M; Nowicki M
Kidney Blood Press Res; 2012; 36(1):18-25. PubMed ID: 22777192
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
18. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
20. Direct renin inhibition--a promising strategy for renal protection?
Lizakowski S; Tylicki L; Rutkowski B
Med Sci Monit; 2013 Jun; 19():451-7. PubMed ID: 23756824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
